🎉 Congratulations to PolarityBio on their BLA submission! The CatalystBio team is proud to have supported PolarityBio on their BLA submission to the U.S. FDA for SkinTE® – a first-in-class autologous cutaneous multicellular therapy targeting diabetic foot ulcers (DFUs). If approved, this would be the… Â
​Â
